A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 7,534 shares of CRSP stock, worth $381,145. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,534
Holding current value
$381,145
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$51.17 - $68.18 $385,514 - $513,668
7,534 New
7,534 $407 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.95B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Mirae Asset Securities (Usa) Inc. Portfolio

Follow Mirae Asset Securities (Usa) Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Securities (Usa) Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Securities (Usa) Inc. with notifications on news.